Polyneuropathy in impotence

Area of Science:

• Neurology
• Urology
• Endocrinology

Background:

• Erectile dysfunction (ED) is a common condition with multifactorial causes.
• Polyneuropathy (PNP) is a potential contributor to ED, particularly in diabetic patients.
• Distinguishing between neurogenic and vasculogenic causes of ED is crucial for effective treatment.

Purpose of the Study:

• To evaluate the prevalence of polyneuropathy (PNP) in impotent patients.
• To assess the utility of neurophysiological and psychophysical tools in diagnosing PNP in this population.
• To determine if specific diagnostic tests can differentiate the causes of impotence.

Main Methods:

• Neurophysiological and psychophysical assessments, including nerve conduction studies and quantitative sensory testing (thermal and vibratory).
• Evaluation of 341 consecutive impotent patients.
• Utilized nocturnal penile tumescence (NPT) testing and vasoactive drug injection tests.

Main Results:

• Overall, 19% of impotent patients exhibited polyneuropathy (PNP).
• PNP prevalence was higher in diabetics (38%) compared to non-diabetics (10%).
• No significant difference in PNP rates was observed between 'neurogenic' (21%) and 'vasculogenic' (23%) impotence, suggesting vasoactive drug injection tests are not discriminatory.

Conclusions:

• Polyneuropathy (PNP) is a common finding in impotent patients and may play a causative role.
• Vasoactive drug injection tests are not effective in differentiating neurogenic from non-neurogenic impotence.
• Nocturnal penile tumescence (NPT) testing reliably distinguishes psychogenic from organic impotence, especially when PNP is a factor, as patients with normal NPT showed very low rates of PNP.